Floatz logo

Gilteritinib

Diagnosis

Gruppo Italiano Malattie EMatologiche dell'AdultoSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Diagnosis cohort.

Asset / SponsorPhaseRating
L-HUPERZINE A
Shanghai Mental Health Center
Phase 4BB
Psma-Hbed-Cc
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
N/AD

Same molecule, other indications

Gilteritinib is also rated in:

acute myeloid leukemia, FLT3 internal tandem duplicationDormant
BB
Indicative ·
69 / 100
View asset →
myelodysplastic syndrome with excess blasts-2Dormant
BB
Indicative ·
66 / 100
View asset →
acute myeloid leukemiaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →